Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas

Clinical trial NCT02030184 · WITHDRAWN

Trial details

NCT number: NCT02030184
Sponsor: University of Maryland, Baltimore
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer (SCLC)Neuroendocrine (NE) Tumors Large Cell Neuroendocrine (NE) Tumors

Start date: 2017-06-01
Primary completion: 2019-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.